F

Active Director Whole-Time Director DIN 08238552
DIN 08238552 First appointment Sep 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Fatima

Data last updated:

Fatima is a Whole-Time Director at Novorem Pharmaceuticals Private Limited (since 2018). The company operates in Trading. Novorem Pharmaceuticals Private Limited reported revenue of ₹2.53 Cr (FY 2025).

DIN 08238552
Primary Designation Whole-Time Director
Industry Trading
First Appointment 14 Sep 2018
Oldest Company Age 13 yrs
Largest company Novorem Pharmaceuticals Private Limited · ₹2.53 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director14 Sep 20182012₹2.53 Cr (FY 2025)Active

Board colleagues of Fatima

NameDINCompanyDesignation
Samiullah Khan06409304Novorem Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Novorem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Fatima

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fatima

Fatima currently holds 1 directorship: Novorem Pharmaceuticals Private Limited (Whole-Time Director, since 14 Sep 2018, revenue ₹2.53 Cr (FY 2025)).

Fatima was first appointed on 14 Sep 2018 as Whole-Time Director at Novorem Pharmaceuticals Private Limited.

The current boards of Fatima's companies include Samiullah Khan (Novorem Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available